Advanced Search

The American Journal of Psychiatry, VOL. 156, No. 7

Letter to the Editor | July 01, 1999

Clozapine to Olanzapine

R.C. MILLSON, M.D.; N.J. DELVA, M.D.

Am J Psychiatry 1999;156:1121-1121.

text A A A

To the Editor: The role of olanzapine in the treatment of severe refractory schizophrenia is unclear. We report our experience in switching five men with refractory schizophrenia and self-induced water intoxication from clozapine to olanzapine.

We stabilized five men with a regimen of clozapine, but they were still too ill to be released from the hospital. We hoped they would have a better response to olanzapine. Their mean age was 40.8 years. Their mean current hospital stay was 13.6 years. The patients were all on a specialized ward for the treatment of self-induced water intoxication. All patients initially had a clozapine blood level greater than 360 ng/ml. One patient also received lithium, and another took valproic acid as an adjuvant to clozapine.

We increased their olanzapine dose and tapered their clozapine dose over a 3-week period. Their mean maximum olanzapine dose was 24 mg/day (range=20–25 mg/day). We obtained an olanzapine blood level on each patient to ensure compliance. We did not alter adjuvant medications. The Positive and Negative Syndrome Scale for Schizophrenia (PANSS) was completed by a psychologist before the start of olanzapine and again after 4 months of treatment or at discontinuation, if this occurred earlier.

We had to discontinue olanzapine in two patients after 2 months when they developed rage attacks. We took two other patients off of olanzapine after 4 months when their psychotic symptoms markedly increased. We left one patient taking olanzapine, because clinically he was unchanged from when he was taking clozapine. The mean PANSS score for the five patients increased from 91.4 to 125.8 (paired t test=2.74, df=4, p=0.05).

The fluid consumption of the five patients, as assessed by weight monitoring, did not increase significantly with olanzapine treatment. As a consequence, the clinical deterioration of the four patients resulted directly from an exacerbation of their schizophrenia rather than through a worsening of their self-induced water intoxication.

On the basis of this open-label study of refractory schizophrenic patients with self-induced water intoxication who were only partially responsive to clozapine, switching from clozapine to olanzapine may not be helpful.

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.

Submit a Comments

Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of JBJS editorial staff.

* = Required Field

Comment Author(s)*(if multiple authors, separate names by comma)

Example: John Doe

Affiliation & Institution*

Comment Title*

Comment*

Cancel

Print
E-mail

Recipient(s) will receive an email with a link (good for 72 hours) to 'Clozapine to Olanzapine' and do not need to have American Journal of Psychiatry account to access the content.
Your Name:*
Example: John Doe

Email Address:* CC Me:
Enter your valid email address. Example: jdoe@example.com

Recipient's Email Address:*
Separate multiple email address with semi-colons (up to 5).

Subject:* 's American Journal of Psychiatry: 'Clozapine to Olanzapine'
Subject for your email.

Message:
(Optional, message will truncate at 1000 characters)

Processing your request... Please Wait...

Copyright © in the material you requested is held by The American Psychiatric Association (unless otherwise noted). This email ability is provided as a courtesy, and by using it you agree that you are requesting the material solely for personal, non-commercial use, and that it is subject to The American Psychiatric Association's Terms of Use. The information provided in order to email this topic will not be used to send unsolicited email, nor will it be furnished to third parties. Please refer to The American Psychiatric Association's Privacy Policy for further information.

Copyright © American Psychiatric Association. All rights reserved.
Share
Get Citation

R.C. MILLSON, N.J. DELVA; Clozapine to Olanzapine. American Journal of Psychiatry. 1999 Jul;156(7):1121-1121.

Download citation file:

RIS (Zotero)

EndNote

BibTex

Medlars

ProCite

RefWorks

Reference Manager

Copyright © American Psychiatric Association. All rights reserved.
Reprints